The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Glucose Intolerance, Insulin Resistance, and Hyperandrogenemia in First Degree Relatives of Women with Polycystic Ovary Syndrome
Open accessAbstract
Polycystic ovary syndrome (PCOS) is associated with hyperinsulinemia, insulin resistance (IR), increased risk of glucose intolerance, and type 2 diabetes. Family studies have indicated a genetic susceptibility to PCOS. The aims of this study were 1) to assess glucose tolerance status, gonadotropins, and androgens in first degree relatives of patients with PCOS; and 2) to assess IR in normal glucose tolerant (NGT) family members. One hundred two family members of 52 patients with PCOS [MothersPCOS (n = 34; mean age, 46.5 yr; mean body mass index (BMI), 28.8 kg/m2), FathersPCOS (n = 24; mean age, 50.4 yr; mean BMI, 27.5 kg/m2), SistersPCOS (n = 19; mean age, 25.1 yr; mean BMI, 22.9 kg/m2), and BrothersPCOS (n = 25; mean age, 23.7 yr; mean BMI, 22.5 kg/m2)] and 82 unrelated healthy control subjects without a family history of diabetes or PCOS (4 age- and weight-matched subgroups, i.e. ControlMothersPCOS, ControlFathersPCOS, ControlSistersPCOS, and ControlBrothersPCOS) were studied. Glucose and insulin (at baseline and during a 75-g, 2-h oral glucose tolerance test) were measured. IR was assessed by fasting insulin (FI), fasting glucose to insulin ratio (FGI), homeostatic model assessment (HOMA IR), and area under the curve for insulin during the oral glucose tolerance test (AUCinsulin) in NGT MothersPCOS, FathersPCOS, SistersPCOS, BrothersPCOS, and matched control subgroups. Including the prestudy-diagnosed 3 mothers and 2 fathers with diabetes, diabetes and impaired glucose tolerance (IGT) were noted in 16% and 30% of MothersPCOS and 27% and 31% of FathersPCOS, respectively. There was no diabetes in SistersPCOS and BrothersPCOS. IGT was found in 5% of SistersPCOS. Impaired fasting glucose was found in 3% of MothersPCOS and 4% of BrothersPCOS. The analysis of NGT family members showed that MothersPCOS had higher FI (P < 0.05), HOMA IR (P < 0.05), and AUCinsulin (P < 0.01) and lower FGI (P < 0.05) than ControlMothersPCOS, whereas all IR parameters were comparable between FathersPCOS and their matched control subgroup. SistersPCOS had higher FI (P < 0.05), HOMA IR (P < 0.01), and AUCinsulin (P < 0.05) and lower FGI (P < 0.01), and BrothersPCOS had higher AUCinsulin (P < 0.01) than their matched control subgroups, respectively. MothersPCOS had higher testosterone levels than ControlMothersPCOS (P < 0.01 and P < 0.05 for pre- and postmenopausal women, respectively). SistersPCOS had higher LH (P < 0.01), testosterone (P < 0.001), androstenedione (P < 0.01), and dehydroepiandrosterone sulfate (P < 0.05) levels than ControlSistersPCOS. There was no difference in gonadotropin and androgen levels in FathersPCOS compared with ControlFathersPCOS or in BrothersPCOS compared with ControlBrothersPCOS. Our results suggest that 1) first degree relatives of patients with PCOS may be at high risk for diabetes and glucose intolerance; 2) NGT female family members have insulin resistance; and 3) mothers and sisters of PCOS patients have higher androgen levels than control subjects. We propose that the high risks of these impairments warrant screening in first degree relatives of patients with PCOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
Dunaif, A. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,458
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
Knochenhauer, E. S., Key, T. J., Kahsar-Miller, M., Waggoner, W., Boots, L. R., & Azziz, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5090 · Cited by 1,516
Asunción, M., Calvo, R. M., San Millán, J. L., Sancho, J., Avila, S., & Escobar-Morreale, H. F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6682 · Cited by 1,318
Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann, D. A., Barnes, R. B., Rosenfield, R. L., Cavaghan, M. K., & Imperial, J. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.141 · Cited by 1,257
Knochenhauer, E. S. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.9.3078 · Cited by 1,127
Diamanti‐Kandarakis, E., Kouli, C., Bergiele, A. T., Filandra, F. A., Tsianateli, T. C., Spina, G., Zapanti, E. D., & Bartzis, M. I. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.11.4006 · Cited by 1,110
Hirsutism: Implications, etiology, and management
Hatch, R., Rosenfield, R. L., Kim, M. H., & Tredway, D. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90746-8 · Cited by 1,014
Health implications of obesity
Pi-Sunyer, F. (1991) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/53.6.1595s · Cited by 809
Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome
Legro, R. S., Driscoll, D., Strauss, J. F., Fox, J., & Dunaif, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14956 · Cited by 699
Dunaif, A. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.3.942 · Cited by 450
Ehrmann, D. A., Sturis, J., Byrne, M. M., Karrison, T., Rosenfield, R. L., & Polonsky, K. S. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118064 · Cited by 426
Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS
Kahsar-Miller, M. D., Nixon, C., Boots, L. R., Go, R. C., & Azziz, R. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01662-9 · Cited by 406
The Associations between Obesity, Adipose Tissue Distribution and Disease
BJÖRNTORP, P. (1987) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1987.tb05935.x · Cited by 403
Weyer, C., Tataranni, P. A., Bogardus, C., & Pratley, R. E. (2001) · Diabetes Care · doi:10.2337/diacare.24.1.89 · Cited by 357
Haffner, S. M., Miettinen, H., Gaskill, S. P., & Stern, M. P. (1995) · Diabetes · doi:10.2337/diab.44.12.1386 · Cited by 303
The genetic basis of polycystic ovary syndrome
Franks, S., Gharani, N., Waterworth, D., Batty, S., White, D., Williamson, R., & McCarthy, M. (1997) · Human Reproduction · doi:10.1093/humrep/12.12.2641 · Cited by 291
Evidence for a single gene effect causing polycystic ovaries and male pattern baldness
Carey, A. H., Chan, K. L., Short, F., White, D., Williamson, R., & Franks, S. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02150.x · Cited by 285
Long-term health consequences of PCOS
Wild, R. A. (2002) · Human Reproduction Update · doi:10.1093/humupd/8.3.231 · Cited by 232
Legro, R. S. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.5.2128 · Cited by 223
Govind, A. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.38 · Cited by 220
American Diabetes Association (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s21 · Cited by 208
Clinical signs of androgen excess as risk factors for coronary artery disease
Wild, R. A., Grubb, B., Hartz, A., Van Nort, J. J., Bachman, W., & Bartholomew, M. (1990) · Fertility and Sterility · doi:10.1016/s0015-0282(16)53699-1 · Cited by 183
Familial Clustering in the Polycystic Ovarian Syndrome
Lunde, O., Magnus, P., Sandvik, L., & Høglo, S. (2010) · Gynecologic and Obstetric Investigation · doi:10.1159/000293493 · Cited by 177
FAMILIAL POLYCYSTIC OVARIES: A GENETIC DISEASE?
HAGUE, W. M., ADAMS, J., REEDERS, S. T., PETO, T. E. A., & JACOBS, H. S. (1988) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1988.tb03707.x · Cited by 174
Legro, R. S. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.5.2134 · Cited by 163
THE INHERITANCE OF POLYCYSTIC OVARIAN DISEASE AND A POSSIBLE RELATIONSHIP TO PREMATURE BALDING
FERRIMAN, D., & PURDIE, A. W. (1979) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1979.tb03077.x · Cited by 161
Wilkerson, H. L. C., Cohen, A. S., & Kenadjian, B. G. (1955) · Journal of Chronic Diseases · doi:10.1016/0021-9681(55)90188-0 · Cited by 155
Phenotype and genotype in polycystic ovary syndrome
Legro, R. S., Spielman, R., Urbanek, M., Driscoll, D., Strauss, J. F., & Dunaif, A. (2001) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545191.003 · Cited by 146
Hyperinsulinemia is common in family members of women with polycystic ovary syndrome
Norman, R. J., Masters, S. C., & Hague, W. M. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58687-7 · Cited by 144
Colilla, S., Cox, N. J., & Ehrmann, D. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7518 · Cited by 138
The android woman – a risky condition
Björntorp, P. A. (1996) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1996.364690000.x · Cited by 102
Diabetes Prevalence and Risk Factors in Polycystic Ovary Syndrome
Legro, R. S. (2001) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70188-1 · Cited by 62
Keleştimur, F., Çetın, M., Paşaoğlu, H., Çoksevim, B., Çeti̇nkaya, F., Ünlühizarci, K., Ünal, S., & H.Köker, A. (1999) · Acta Diabetologica · doi:10.1007/s005920050150 · Cited by 48
Genetics of Type 2 Diabetes: An Overview for the Millennium
Elbein, S. C. (2000) · Diabetes Technology & Therapeutics · doi:10.1089/15209150050194260 · Cited by 10
Cited by
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132
“Abnormalities of carbohydrate metabolism such as insulin resistance, impaired glucose tolerance, type 2 DM tend to cluster in families with PCOS (33, 34).”
BackgroundDiamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Rosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603
Metadata
- Authors
- Yildiz, B. O., Yarali, H., Oguz, H., & Bayraktar, M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-05-01
- Volume
- 88
- Issue
- 5
- Pages
- 2031-2036
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2148120261
- Cited by
- 275
- References
- 39
- FWCI
- 13.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.